What were the primary endpoints of the PSOARING 1 and PSOARING 2 trials for tapinarof?
Featuring Tina Bhutani-Jacques, MD, MAS | Synergy Dermatology San Francisco, CA | Published April 08, 2024
Related Media
Powered by Polaris TMFeaturing Tina Bhutani-Jacques, MD, MAS | Synergy Dermatology San Francisco, CA | Published April 08, 2024
Related Media
Powered by Polaris TM